Thermo Fisher Scientific to Acquire QIAGEN N.V.

Author's Avatar
Mar 03, 2020
Article's Main Image

- Expands specialty diagnostics portfolio with attractive molecular diagnostics capabilities, including infectious disease testing

- Complements leading life sciences offering with innovative sample preparation, assay and bioinformatics technologies

- Creates significant value and is expected to be immediately accretive to adjusted earnings per share after close

PR Newswire